| Literature DB >> 33133376 |
Shuntaro Yoshida1, Toshihiro Nishizawa1, Osamu Toyoshima2.
Abstract
The impact of the coronavirus disease 2019 (COVID-19) pandemic is widespread throughout the world, causing serious damage to healthcare systems. Therefore, we examined the significance of endoscopy based on the recommendation of Asian-Pacific Society for Digestive Endoscopy and Japan Gastroenterological Endoscopy Society during the COVID-19 pandemic by evaluating the details of gastrointestinal endoscopy performed during the declaration of emergency in Japan. We have continued performing gastrointestinal endoscopy at an outpatient clinic that specialized in endoscopic medical care in Tokyo, Japan. During the emergency declaration period, 544 patients underwent gastrointestinal endoscopy. As a control, we investigated 1327 patients who underwent gastrointestinal endoscopy during the same period in 2019. Although the total number of endoscopies during the emergency declaration was halved, the advanced cancer detection rate during the emergency declaration was significantly higher than that in 2019 (P = 0.04). Additionally, no COVID-19 infection was observed in healthcare workers, staff, or patients during this period. It is possible that an outpatient endoscopy units can contribute to the detection of advanced cancer, while the hospital in charge for patients with COVID-19 infection could not perform endoscopy during the declaration of emergency. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.Entities:
Keywords: COVID-19; Endoscopy; Gastrointestinal; Neoplasms; Pandemics; Personal protective equipment
Year: 2020 PMID: 33133376 PMCID: PMC7579523 DOI: 10.4253/wjge.v12.i10.401
Source DB: PubMed Journal: World J Gastrointest Endosc
Figure 1A surgical mask for patient during procedure with a handmade scope insertion port.
Comparison of gastrointestinal endoscopy performed in 2019 and 2020
|
|
|
|
|
| Upper endoscopy, | 311 | 790 | |
| Colonoscopy, | 233 | 537 | |
| Total, | 544 | 1327 | |
| Age (yr ± SD) | 55.2 ± 13.4 | 55.8 ± 13.2 | 0.34 |
| Sex, male (%) | 53.9 | 47.3 | 0.01 |
| All malignancies, | 6 (1.1) | 8 (0.6) | 0.40 |
| Advanced lesion, | 5 (0.9) | 2 (0.2) | 0.04 |
| Early lesion, | 1 (0.2) | 6 (0.5) | 0.66 |